AKL Research & Development Limited, trading as AKL Therapeutics, is based at the Stevenage Bioscience Catalyst, Stevenage, Herts UK. AKL identifies and synthesizes secondary metabolites of plant origin with proven efficacy & safety. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects. AKL is focused on developing its lead clinical asset APPA, a novel ther...
AKL Research & Development Limited, trading as AKL Therapeutics, is based at the Stevenage Bioscience Catalyst, Stevenage, Herts UK. AKL identifies and synthesizes secondary metabolites of plant origin with proven efficacy & safety. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects. AKL is focused on developing its lead clinical asset APPA, a novel therapeutic for inflammatory diseases where there is a high unmet need, including osteoarthritis (OA) and other complex diseases of ageing.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.